Malignant Gastric Neoplasm — Trials

Malignant Gastric Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,844 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 650
Recruiting: 353
Ph III recruiting: 49
Growth YoY: +15.1%
Industry share: 26%
Top sponsor: Fudan University
Termination share: 26.1%
Trials / 1,000 deaths: 59.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (232)

clinicaltrialsPublishedShowing 301–350 of 755 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04915807	Real-world Data (RWD) of Ramucirumab Plus Paclitaxel	unknown	—	222	Hallym University Medical CenterOTHER	1	Jun 7, 2021	clinicaltrials
NCT04913896	CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy	unknown	—	200	The First Hospital of Jilin UniversityOTHER	0	Jun 4, 2021